Chapter 4 The Controversial Role of Mast Cells in Tumor Growth

International Review of Cell and Molecular Biology

Volumn 275, Issue C, 2009, Pages 89-131

  Ribatti, Domenico ^a   Crivellato, Enrico ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Mast cells; Tumor progression

Indexed keywords

ACID HYDROLASE; ALPHA INTERFERON; CARBOXYPEPTIDASE; CATHEPSIN G; CHONDROITIN 4 SULFATE; CHYMASE; DERMATAN SULFATE; HEPARIN; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE B4; LEUKOTRIENE C4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR BASIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXIDASE; PHOSPHORYLASE; PROSTAGLANDIN E2; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC REACTION; ANGIOGENESIS; B CELL LYMPHOMA; BACTERIAL INFECTION; CARCINOGENESIS; CELL FUNCTION; CELL INFILTRATION; CELL MATURATION; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FIBROSIS; GROWTH STIMULATION; HODGKIN DISEASE; HOMEOSTASIS; HOST RESISTANCE; HUMAN; INFLAMMATORY CELL; INNATE IMMUNITY; LUNG NON SMALL CELL CANCER; LYMPHANGIOGENESIS; MAST CELL; MELANOMA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PARASITOSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TISSUE REGENERATION; TISSUE REPAIR; TUMOR GROWTH; VIRUS INFECTION; ANIMAL; INFLAMMATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATION; MAST CELLS; NEOPLASMS;

EID: 66149120295     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1937-6448(09)75004-X     Document Type: Review

References (227)

1. Aaltomaa S., Lipponen P., Papinaho S., and Kosma V.M. Mast cells in breast cancer. Anticancer Res. 13 (1993) 785-788
2. Akin C., and Metcalfe D.D. The biology of Kit in disease and the application of pharmacogenetics. J. Allergy Clin. Immunol. 114 (2004) 13-19
3. Alessandri G., Raju K.S., and Gullino P.M. Characterization of a chemoattractant for endothelium induced by angiogenic effectors. Cancer Res. 44 (1984) 1579-1584
4. Arinobu Y., Iwasaki H., Gurish M.F., Mizuno S., Shigematsu H., Ozawa H., Tenen D.G., Austen K.F., and Akashi K. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl. Acad. Sci. USA 102 (2005) 18105-18110
5. Artuc M., Hermes B., Steckelings M.U., Grutzkau A., and Henz B.M. Mast cells and their mediators in wound-healing-Active participants or innocent bystanders?. Exp. Dermatol. 8 (1999) 1-16
6. Artuc M., Steckelings M., and Henz B.M. Mast cell-fibroblast interactions: Human mast cells as source and inducer of fibroblast and epithelial growth factors. J. Invest. Dermatol. 118 (2002) 391-395
7. Ashman L.K. The biology of stem-cell factor and its receptor c-kit. Int. J. Biochem. Cell Biol. 31 (1999) 1037-1051
8. Baram D., Vaday G., Salamon P., Drucker I., Hershkoviz R., and Mekori Y.A. Human mast cells release metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-alpha. J. Immunol. 167 (2001) 4009-4016
9. Benitez-Bribiesca L., Wong A., Utrera D., and Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J. Histochem. Cytochem. 49 (2001) 1061-1062
10. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., Tonnesen M.G., and Gruber B.L. Tryptase is a novel, potent angiogenic factor. J. Clin. Invest. 99 (1997) 2691-2700
11. Blank U., and Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25 (2004) 266-273
12. Bochner B.S., Charlesworth E.N., Lichtenstein L.M., Derse C.P., Gillis S., Dinarello C.A., and Schleimer R.P. Interleukin-1 is released at sites of human cutaneous allergic reactions. J. Allergy Clin. Immunol. 86 (1990) 830-839
13. Boesiger J., Tsai M., Maurer M., Yamaguki M., Brown L.F., Claffey K.P., Dvorak H.F., and Galli S.J. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J. Exp. Med. 188 (1998) 1135-1145
14. Boyce J.A., Mellor E.A., Perkins B., Lim Y.C., and Luscinskas F.W. Human mast cell progenitors use α4 integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 99 (2002) 2890-2896
15. Bradding P., Feather I.H., Wilson S., Bardin P.G., Heusser C.H., Holgate S.T., and Howarth P.H. Immonolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151 (1993) 3853-3865
16. Bradding P., Okayama Y., Howzrth P.H., and Church M.K. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155 (1995) 297-307
17. Brideau G., Makinen M.J., Elamaa H., Tu H., Nilsson G., Alitalo K., Pihlajaniemi T., and Heljasvaara R. Endostatin overexpression inhibits lymhangiogenesis and lymph node metastasis in mice. Cancer Res. 67 (2007) 11528-11535
18. Brody D., and Metcalfe D.D. Mast cells: A unique and functional diversity. Clin. Exp. Allergy 28 (1998) 1167-1170
19. v, W/+, and +/+ mice. J. Natl. Cancer Inst. 74 (1985) 671-674
20. Cairns J.A., and Walls A.F. Mast cell tryptase stimulate the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 99 (1997) 1313-1321
21. Cantarella G., Lempereur L., Presta M., Ribatti D., Lombardo G., Lazarovici P., Zappalà G., Pafumi C., and Bernardini R. Nerve growth factor-endothelial cell interactions lead to angiogenesis in vitro and in vivo. FASEB J. 16 (2002) 1307-1309
22. Caplan R.M. The natural course of urticaria pigmentosa. Arch. Dermatol. 87 (1963) 146-157
23. Castellot J.J., Karnovsky M.J., and Spiegelman B.M. Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc. Natl. Acad. Sci. USA 79 (1982) 5597-5601
24. Chan J.K., Magistris A., Loizzi V., Lin F., Rutgers J., Osann K., DiSaia P.J., and Samoszuk M. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol. Oncol. 99 (2005) 20-25
25. Chen R., Fairley J.A., Zhao M.L., Giudice G.J., Zillikens D., Diaz L.A., and Lin Z. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: Macrophage-mediated neutrophil infiltration depends on mast cell activation. J. Immunol. 169 (2002) 3987-3992
26. Christy A.L., and Brown M.A. The multitasking mast cell: Positive and negative roles in the progression of autoimmunity. J. Immunol. 179 (2007) 2673-2679
27. Church M., and Levi-Schaffer F. The human mast cell. J. Allergy Clin. Immunol. 99 (1997) 155-160
28. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., Thibault J., and Theoharides T.C. Impact of Rantes and MCP-1 chemokines on in vivo basohilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89 (1997) 4120-4127
29. Coussens L.M., Raymond W.W., Bergers G., Lain-Webster M., Behrendtsen O., Werb Z., Caughey G.H., and Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13 (1999) 1382-1397
30. Crivellato E., Nico B., Vacca A., Dammacco F., and Ribatti D. Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: An ultrastructural study. Leuk. Lymphoma 43 (2002) 2201-2205
31. Crivellato E., Beltrami C., Mallardi F., and Ribatti D. Paul Ehrlich's doctoral thesis: A milestone in the study of mast cells. Br. J. Haematol. 123 (2003) 19-21
32. Crivellato E., Nico B., Vacca A., and Ribatti D. Ultrastructural analysis of mast cell recovery after secretion by piecemeal degranulation in B-cell non-Hodgkin's lymphoma. Leuk. Lymphoma 44 (2003) 517-521
33. Dabbous M., Walker R., Haney L., Carter L.M., Nicolson G.L., and Woolley D.E. Mast cells and matrix degradation at sites of tumor invasion in rat mammary adenocarcinoma. Br. J. Cancer 54 (1986) 459-465
34. Dabiri S., Huntsman D., Makretsov N., Cheang M., Gilks B., Bajdik C., Gelmon K., Chia S., and Hayes M. The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod. Pathol. 17 (2004) 690-695
35. Dave S.S., Wright G., Than B., Rosenwald A., Gascoyne R.D., Chan W.C., Fisher R.I., Braziel R.M., Rimsza L.M., Grogan T.M., Miller T.P., Le Blanc M., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor infiltrating immune cells. N. Engl. J. Med. 351 (2004) 2159-2169
36. Demeure C.E., Brahimi K., Hacini F., Marchand F., Peronet R., Huerre M., St-Mezard P., Nicolas J.F., Brey P., Delespesse G., and Mecheri S. Anopheles moschito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J. Immunol. 174 (2005) 3932-3940
37. Di Girolamo N., and Wakefiled D. In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Dev. Immunol. 7 (2000) 131-142
38. Dvorak A.M. Basophil and mast cell degranulation and recovery. In: Harris J.R. (Ed). Blood Cell Biochemistry Vol. 4 (1991), Plenum Press, New York
39. Dvorak A.M. Ultrastructural studies of human basophils and mast cells. J. Histochem. Cytochem. 53 (2005) 1043-1070
40. Dvorak A.M., and Kissel S. Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ. J. Leuk. Biol. 49 (1991) 197-210
41. Echternacher B., Männel D.N., and Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 (1996) 75-77
42. Edwards A.M. Oral sodium cromoglycate: Its use in the management of food allergy. Clin. Exp. Allergy 25 Suppl. 1 (1995) 31-33
43. Ehrlich P. Beiträge zur Theorie und Praxis der Histologischen Färbung (1878), Leipzig University, Germany PhD Thesis
44. Elbadawi A. Interstitial Cystitis: A critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49 Suppl. 5A (1997) 14-40
45. Elpek G.O., Gelen T., Aksoy N.H., Erdogan A., Dertsiz L., Dermican A., and Keles N. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J. Clin. Pathol. 54 (2001) 940-944
46. Emanueli C., Salis M.B., Pinna A., Graiani G., Manni L., and Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106 (2002) 2257-2262
47. Enerback L. Mast cell heterogeneity: The evolution of the concept of a specific mucosal mast cell. In: Befus A.D., Bienenstock J., and Denburg J.A. (Eds). Mast Cell Differentiation and Heterogeneity (1986), Raven Press, New York 1-26
48. Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., and Caughey G.H. Mast cell expression of gelatinase A and B is regulated by kit ligand and TGF-β. J. Immunol. 162 (1999) 5528-5535
49. Féger F., Varadaradjalou S., Gao Z., Abraham S.N., and Arock M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 23 (2002) 151-158
50. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
51. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., Eriksson I., Ledin J., Hellman L., and Kjellen L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400 (1999) 773-776
52. Frangogiannis N.G., Lindsey M.L., Michael L.H., Youker K.A., Bressler R.B., Mendoza L.H., Spengler R.N., Smith C.W., and Entman M.L. Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98 (1998) 699-710
53. Fukushima N., Satoh T., Sano M., and Tokunaga O. Angiogenesis and mast cells in non-Hodgkin's lymphoma: Strong correlation in angioimmunoblastic T-cell lymphoma. Leuk. Lymphoma 42 (2001) 709-720
54. Fukushima H., Ohsawa M., Ikura Y., Naruko T., Sugama Y., Suekane T., Kitabayashi C., Inoue T., Hino M., and Ueda M. Mast cells in diffuse large B-cell lymphoma; Their role in fibrosis. Histopathology 49 (2006) 498-505
55. Fureder W., Agis H., Willheim M., Bankl H.C., Maier U., Kishi K., Muller M.R., Czerwenka K., Radaszkiewicz T., Butterfield J.H., Klappacher G.W., Sperr W.R., et al. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155 (1995) 3152-3160
56. Galli S.J. New insight into "the riddle of mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62 (1990) 5-33
57. Galli S.J., and Lantz C.S. Allergy. In: Paul W.E. (Ed). Fundamental Immunology (1999), Lippincot-Raven, Philadelphia, PA 1137-1184
58. Galli S.J., Tsai M., Gordon J.R., Geissler E.N., and Wershil B.K. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci. Ann. NY Acad. Sci. 664 (1992) 69-88
59. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
60. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
61. Galli S.J., Grimbaldeston M., and Tsai M. Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 8 (2008) 445-454
62. Galli S.J., Tsai M., and Piliponski A.M. The development of allergic inflammation. Nature 454 (2008) 445-454
63. Glimelius I., Edström A., Fischer M., Nilsson G., Sundström C., Molin D., Amini R.M., and Enblad G. Angiogenesis and mast cells in Hodgkin lymphoma. Leukemia 19 (2005) 2360-2362
64. Gombert M., Dieu-Nosjean M.C., Winterberg F., Bunemann E., Kubitza R.C., Da Cunha L., Haahtela A., Lehtimäki S., Müller A., Rieker J., Meller S., Pivarcsi A., et al. CCL1-CCR8 interactions: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174 (2005) 5082-5091
65. Gommerman J.L., Oh D.Y., Zhou X., Tedder T.F., Maurer M., Galli S.J., and Carroll M.C. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: A potential mechanism for mast cell activation. J. Immunol. 165 (2000) 6915-6921
66. Gooch S.J., Lee A.V., and Yee D. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 58 (1998) 4199-4205
67. Gordon J.R., and Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346 (1990) 274-276
68. Gordon J.R., and Galli S.J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174 (1991) 103-107
69. Gounaris E., Erdman S.E., Restaino C., Gurish M.F., Friend D.S., Gounari F., Lee D.M., Zhang G., Glickman J.N., Shin K., Rao V.P., Poutahidis T., et al. Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. USA 104 (2007) 19977-19982
70. H 1 responses in mice. J. Clin. Invest. 116 (2006) 1327-1336
71. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167 (2005) 835-848
72. Grimbaldeston M.A., Nakae S., Kalesnikoff K., Tsai M., and Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 38 (2007) 1095-1104
73. Gruber B.L., Marchese M.J., Suzuki K., Schwartz L.B., Okada Y., Nagase H., and Ramamurthy N.S. Synovial procollagenase activation by human mast cell tryptase dependence upom matrix metalloproteinase 3 activation. J. Clin. Invest. 84 (1989) 1657-1662
74. Gruber B.L., Marchese M.J., and Kew R.R. Transforming growth factor-β1 mediates mast cell chemotaxis. J. Immunol. 152 (1994) 5860-5867
75. Gruber B.L., Kew R.R., Jelaska A., Marchese M.J., Garlick J., Ren S., Schwartz W.B., and Korn J.H. Human mast cells activate fibroblasts. J. Immunol. 158 (1997) 2310-2317
76. Grutzkau A., Kruger-Krasagakes S., Baumeister H., Schwarz C., Kogel H., Welker P., Lippert U., Hemz G.M., and Moller A. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF 206. Mol. Biol. Cell 9 (1998) 875-884
77. Guidolin D., Crivellato E., Nico B., Andreis P.G., Nussdorfer G.G., and Ribatti D. An image analysis of the spatial distribution of perivascular mast cells in human melanoma. Int. J. Mol. Med. 17 (2006) 981-987
78. Guidolin D., Nico B., Crivellato E., Marzullo E., Vacca A., and Ribatti D. Tumoral mast cells exhibit a common spatial distribution. Cancer Lett. 273 (2008) 80-85
79. Gurish M.F., and Austen K.F. The diverse role of mast cells. J. Exp. Med. 194 (2001) 1-5
80. Gurish M.F., and Boyce J.A. Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell. J. Allergy Clin. Immunol. 117 (2006) 1285-1291
81. Guy-Grand D., Dy M., Luffau G., and Vassalli P. Gut mucosal mast cells. Origin, traffic and differentiation. J. Exp. Med. 160 (1984) 12-28
82. Halaban R., Kwon B.S., Ghosh S., Delli Bovi P., and Baird A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3 (1988) 177-186
83. Hara M., Matsumori A., Ono K., Kido H., Hwang M.W., Miyamoto T., Iwasaki A., Okada M., Nakatani S., and Sasayama S. Mast cells cause apotosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 100 (1999) 1443-1449
84. Hart P., Grimbaldeston M., and Finlay-Jones J. Immunosuppression and skin cancer: Role of histamine and mast cells. Clin. Exp. Pharmacol. Physiol. 28 (2001) 1-8
85. Hart P., Townley S., Grimbaldeston M., Khalil Z., and Finaly-Jones J.J. Mast cells, neuropeptides, histamine and prostaglandins in UV-induced systemic immunosuppression. Methods 28 (2002) 79-89
86. Heinrich M.C., Griffith D.J., Druker B.J., Wait C.L., Ott K.A., and Zigler A.J. Inhibition of c-kit receptor tyrosine kinase activity by STI 571 a selective tyrosine kinase inhibitor. Blood 96 (2000) 925-932
87. He S., and Walls A.F. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br. J. Pharmacol. 125 (1998) 1491-1500
88. Huang C., Sali A., and Stevens R.L. Regulation and function of mast cell proteases in inflammation. J. Clin. Immunol. 18 (1998) 169-183
89. Huang B., Lei Z., Zhang G.M., Li D., Song C., Li B., Liu Y., Yuan Y., Unkeless J., Xiong H., and Feng Z.H. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112 (2008) 1269-1279
90. Humphries D.E., Wong G.W., Friend D.S., Gurish M.F., Qiu W.T., Huang C., Sharpe A.H., and Stevens R.L. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400 (1999) 769-772
91. Humrich J.Y., Humrich J.H., Averbeck M., Thumann P., Termeer C., Kämpgen E., Schuler G., and Jenne L. Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: Consequences for directional migration. Immunology 117 (2006) 238-247
92. Iamaroon A., Pongsiriwet S., Jittidecharaks S., Pattanaporn K., Prapayasatok S., and Wanachantararak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral. Pathol. Med. 32 (2003) 195-199
93. Imada D., Shijubo N., Kojima H., and Abe S. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur. Respir. J. 15 (2000) 1087-1093
94. Irani A.M., and Schwartz L.B. Human mast cell heterogeneity. Allergy Proc. 15 (1994) 303-308
95. Irani A.M., Schechter N.M., Craig S.S., De Blois G., and Schwzrtz L.B. Two types of human mast cells that have distinct neutral protease composition. Proc. Natl. Acad. Sci. USA 83 (1986) 4464-4468
96. Jakobson A.M., and Hahnenberger R. Antiangiogenic effect of heparin and other sulphated glycosaminoglycans in the chick embryo chorioallantoic membrane. Pharmacol. Toxicol. 69 (1991) 122-126
97. Jawdat D.M., Rowden G., and Marshall J.S. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J. Immunol. 177 (2006) 1755-1762
98. Johnson A.R., Hugli T.E., and Müller-Eberhard H.J. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28 (1975) 1067
99. Kakurai M., Monteforte R., Suto H., Tsai M., Nakae S., and Galli S.J. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am. J. Pathol. 169 (2006) 1713-1721
100. Kambayashi T., Baranski J.D., Baker R.G., Zou T., Allenspach E.J., Shoag J.E., Jones P.L., and Korezky G.A. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 111 (2008) 1489-1496
101. Kankkunen J.P., Harvima I.T., and Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int. J. Cancer 72 (1997) 385-388
102. Kenny P.A., Mc Donald P.J., and Finlay-Jones J.J. The effect of cytokines on bactericidal activity of murine neutrophils. FEMS Immunol. Med. Microbiol. 7 (1993) 271-279
103. Kessler D.A., Langer R.S., Pless N.A., and Folkman J. Mast cells and tumor angiogenesis. Int. J. Cancer 18 (1976) 703-709
104. + bone marrow progenitor cells. J. Immunol. 146 (1991) 1410-1415
105. Kitamura Y., and Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell. Mol. Life Sci. 61 (2004) 2924-2931
106. Kitamura Y., Shimada M., Hatanaka K., and Miyano Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268 (1977) 442-443
107. v mice and their increase by bone marrow transplantation. Blood 52 (1978) 447-452
108. Knight P.A., Wright S.H., Lawrence C.E., Paterson Y.Y., and Miller H.R. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mause mast cell protease-1. J. Exp. Med. 192 (2000) 1849-1856
109. Kops S.K., Van Loveren H., Rosenstein R.W., Ptak W., and Askenase P.W. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T-cell derived antigen-binding factor. Lab. Invest. 50 (1984) 421-434
110. Lantz C.S., Boesinger J., Song C.H., March N., Kobayashi T., Mulligan R.C., Nawa Y., Dranoff G., and Galli S.J. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 329 (1998) 90-93
111. Lazar-Molnar E., Hegyesi H., Pallinger E., Kovacs P., Toth S., Fitzsimons C., Cricco G., Martin G., Bergoc R., Darvas Z., Rivera E.S., and Falus A. Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur. J. Clin. Invest. 32 (2002) 743-749
112. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 297 (2002) 1689-1692
113. Lennert K., and Parwaresch M.R. Mast cells and mast cell neoplasia: A review. Histopathology 3 (1979) 349-365
114. Liebler J.M., Picou M.A., Qu Z., Powers M.R., and Rosembaum J.T. Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury. Growth Factors 14 (1997) 25-38
115. Lorentz A., and Bischoff S.C. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol. Rev. 179 (2001) 57-60
116. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., Strom T.B., Zheng X.X., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 997-1002
117. Malaviya R., Ikeda T., Ross E., and Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381 (1996) 77-80
118. Markwardt F., and Klocking H. Heparin-induced release of plasminogen activator. Haemostasis 6 (1977) 370-374
119. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4 (2004) 787-799
120. Masini E., Bechi P., Dei R., Di Bello M.G., and Sacchi T.B. Helicobacter pylori potentiates histamine release from rat serosal mast cells induced by bile acids. Dig. Dis. Sci. 39 (1994) 1493-1500
121. Maurer M., Echternacher B., Hültner L., Kollias G., Mannel D.N., Langley K.E., and Galli S.J. The c-kit ligand, stem-cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188 (1998) 2343-2348
122. Maurer M., Wedemeyer J., Metz M., Piliponsky A.M., Weller K., Chatterjea D., Clouthier D.E., Yanagisawa M.M., Tsai M., and Galli S.J. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432 (2004) 512-516
123. Maurer M., Lopez Kostka S., Siebenhaar F., Moelle K., Metz M., Knop J., and von Stebut E. Skin mast cells control T cell-dependent host defence in Leishmania major infections. FASEB J. 20 (2006) 2460-2467
124. McDonald D.M., and Boluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 62 (2002) 5381-5385
125. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
126. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., and Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 313 (2006) 526-530
127. Miller H.R., and Pemberton A.D. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105 (2002) 375-390
128. Miller J.S., Westin E.H., and Schwartz L.B. Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest. 84 (1989) 1188-1195
129. Miller J.S., Moxley G., and Schwartz L.B. Cloning and characterization of a second complementary DNA for human tryptase. J. Clin. Invest. 86 (1990) 864-870
130. Molica S., Vacca A., Crivellato E., Cuneo A., and Ribatti D. Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Eur. J. Haematol. 71 (2003) 137-139
131. Molica S., Montillo M., Ribatti D., Mirabelli R., Tedeschi A., Ricci F., Veronese S., Vacca A., and Morra A. Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia. Haematologica 92 (2007) 1367-1374
132. Molin D. Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis. Ups. J. Med. Sci. 109 (2004) 179-228
133. Molin D., Edstrom A., Glimelius I., Glimelius B., Nilsson G., Sundstrom C., and Enblad G. Mast cell infilltration correlates with poor prognosis in Hodgkin's lymphoma. Br. J. Haematol. 119 (2002) 122-124
134. Moller A., Lippert U., Lessmann D., Kolde G., Hamann K., Welker P., Schadendorf D., Rosenbach T., Luger T., and Czarnetzki B.M. Human mast cells produce IL-8. J. Immunol. 151 (1993) 3261-3266
135. Muramatsu M., Katada J., Hattori M., Hayashi I., and Majima M. Chymase mediates mast cell-induced angiogenesis in the hamster sponge granuloma. Eur. J. Pharmacol. 402 (2000) 181-191
136. Muramatsu M., Katada J., Hattori M., Hayashi I., and Majima M. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J. Biol. Chem. 275 (2000) 5545-5552
137. Nakae S., Suto H., Hakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 102 (2005) -6472
138. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176 (2006) 2238-2248
139. Nakajima S., Krishnan B., Ota H., Segura A.M., Hattori T., Graham D.Y., and Genta R.M. Mast-cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology 113 (1997) 746-754
140. Nakayama T., Yao L., and Tosato G. Mast cell-derived amgiopoietin-1 plays a role in the growth of plasma cell tumors. J. Clin. Invest. 114 (2004) 1317-1325
141. Nechushtan H., and Razin E. The function of MIFT and associated proteins in mast cells. Mol. Immunol. 38 (2002) 1177-1180
142. Nielsen H.J., Christenseb I.J., Svendsen M.N., Hansen U., Werther K., Brunner N., Petersen L.J., and Kristensen J.K. Ranitidine as adjuvant treatment in colorectal cancer. Br. J. Surg. 89 (2002) 1416-1422
143. Nigrovic P.A., and Lee D.M. Synovial mast cells: Role in acute and chronic arthritis. Immunol. Rev. 217 (2007) 19-37
144. Niwa Y., Kasugai T., Ohno K., Morimoto M., Yamazaki M., Dohmae K., Nishimune Y., Kondo K., and Kitamura Y. Anemia and mast cells depletion in mutant rats that are homozygous at 'white spotting (Ws)' locus. Blood 78 (1991) 1936-1941
145. 41 and W. EMBO J. 9 (1990) 1805-1813
146. Nonomura N., Takayama H., Nishimura K., Oka D., Nakai Y., Shiba M., Tsujimura A., Nakayama M., Aozasa K., and Okuyama A. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br. J. Cancer 97 (2007) 952-956
147. Norrby K. Heparin and angiogenesis: A low molecular weight fraction inhibits and a high molecular weight fraction stimulates angiogenesis systematically. Haemostasis 23 (1993) 144-149
148. Norrby K., and Sorbo J. Heparin enhances angiogenesis by a systemic mode of action. Int J. Exp. Pathol. 73 (1992) 1451-1455
149. Norris A.A. Pharmacology of sodium cromoglycate. Clin. Exp. Allergy 26 Suppl 4 (1996) 5-7
150. Ochi H., Hirani W.M., Yuan Q., Friend D.S., Austen K.F., and Boyce J.A. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190 (1999) 267-280
151. Ohno S., Inagawa H., Soma G., and Nagasue N. Role of tumor-associated macrophage in malignant tumors: Should the location of the infiltrated macrophages be taken into account during evaluation?. Anticancer Res. 22 (2002) 4269-4275
152. Okayama Y., and Kawakami T. Development, migration, and survival of mast cells. Immunol. Res. 34 (2006) 97-115
153. Olsson N., Ulfgren A.K., and Nilsson G. Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann. Rheum. Dis. 60 (2001) 187-193
154. Orinska Z., Maurer M., Mirghomizadeh F., Bulanova E., Metz M., Nashkevich N., Schiemann F., Schulmistrat J., Budagian V., Giron-Michel V., Brandt E., Paus R., et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nature Med. 13 (2007) 927-934
155. + T cells through production of leukotriene B4. Nat. Immunol. 4 (2003) 974-981
156. Pardanani A., Elliott M., Reeder T., Li C.Y., Baxter E.J., Cross N.C., and Tefferi A. Imatinib for systemic mast cell disease. Lancet 362 (2003) 535-536
157. Parshad R., Kapoor S., Gupta S.D., Kumar A., and Chattopadhyaya T.K. Does famotidine enhance tumor infilitrating lymphocytes in breast cancer? Results of a randomized prospective pilot study. Acta Oncol. 41 (2002) 362-365
158. Piliponsky A.M., Chen C.C., Nishimura T., Metz M., Rios E.J., Dobner P.R., Wada E., Wada K., Zacharias S., Mohanasundaram U.M., Faix J.D., Abrink M., et al. Neurotensin incrases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat. Med. 14 (2008) 392-398
159. Plebani M., Basso D., Vianello F., and Di Mario F. Helicobacter pylori activates gastric mucosal mast cells. Dig. Dis. Sci. 39 (1994) 1592-1593
160. Poole T.J., and Zetter B.R. Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. Cancer Res. 43 (1983) 5857-5861
161. Prodeus A.P., Zhou X., Maurer M., Galli S.J., and Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390 (1997) 172-175
162. Pulimood A.B., Mathan M.M., and Mathan V.I. Quantitative and ultrastructural analysis of rectal mucosal mast cells in acute infectious diarrhea. Dig. Dis. Sci. 43 (1998) 2111-2116
163. Qu Z., Kayton R.J., Ahmadi P., Liebler G.M., Powers M.R., Planck S.R., and Rosembaum J.M. Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules: Morphological evidence for bFGF release through degranulation. J. Histochem. Cytochem. 46 (1998) 1119-1128
164. Rauter I., Krauth M.T., Westritschnig K., Horak F., Flicker S., Gieras A., Repa A., Balic N., Spitzauer S., Huss-Marp J., Brockow K., Darsow U., et al. Mast cell-derived proteases control allergic inflammation through cleavage of IgE. J. Allergy Clin. Immunol. 121 (2008) 197-202
165. Raza S.L., and Cornelius L.A. Matrix metalloproteinases: Pro- and anti-angiogenic activities. J. Invest. Dermatol. Symp. Proc. 5 (2000) 47-54
166. Ribatti D., Roncali L., Nico B., and Bertossi M. Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat. 130 (1987) 257-263
167. Ribatti D., Nico B., Vacca A., Marzullo A., Calvi N., Roncali L., and Dammacco F. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?. Br. J. Cancer 77 (1998) 1900-1906
168. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L., and Dammacco F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br. J. Cancer 79 (1999) 451-455
169. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L., and Dammacco F. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int. J. Cancer 82 (2000) 171-175
170. Ribatti D., Crivellato E., Candussio L., Nico B., Vacca A., Roncali L., and Dammacco F. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin. Exp. Allergy 31 (2001) 602-608
171. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., Lucarelli G., and Dammacco F. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16 (2002) 1680-1684
172. Ribatti D., Vacca A., Ria R., Marzullo A., Nico B., Filotico R., Roncali L., and Dammacco F. Neovascularization, expression of fibroblast growth factor-2, and mast cell with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer 39 (2003) 666-675
173. Ribatti D., Ennas M.G., Vacca A., Ferrelli F., Nico B., Orru S., and Sirigu P. Tumor vascularity and tryptase positive-mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Invest. 33 (2003) 420-425
174. Ribatti D., Molica S., Vacca A., Nico B., Crivellato E., Roccaro A.M., and Dammacco F. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 17 (2003) 1428-1430
175. Ribatti D., Finato N., Crivellato E., Marzullo A., Mangieri D., Nico B., Vacca A., and Beltrami C.A. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am. J. Obstet. Gynecol. 193 (2005) 1961-1965
176. Ribatti D., Finato N., Crivellato E., Guidolin D., Longo V., Mangieri D., Nico B., Vacca A., and Beltrami C.A. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathology 51 (2007) 837-842
177. Rodewald H.R., Dessing M., Dvorak A.M., and Galli S.J. Identification of a committed precursor for the mast cell lineage. Science 271 (1996) 818-822
178. Rojas I.G., Spencer M.L., Martinez A., Maurelia M.A., and Rudolph M.I. Characterization of mast cell subpopulations in lip cancer. J. Oral Pathol. Med. 34 (2005) 268-273
179. Ruoss S.J., Hartmann T., and Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88 (1991) 493-499
180. Saito H. Culture of human mast cells from hemopoietic progenitors. Methods Mol. Biol. 315 (2005) 113-122
181. Sakamoto S., Goldhaber P., and Glimcher M. The effect of heparin on the amount of enzyme released in tissue culture and on the activity of the enzyme. Calcif. Tissue Int. 12 (1973) 247-258
182. Samoszuk M., and Corwin M.A. Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer. Int. J. Cancer 107 (2003) 159-163
183. Sawatsubashi M., Yamada T., Fukushima N., Mizokami H., Tokunaga O., and Shin T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 436 (2000) 243-248
184. Sayed B.A., Christy A., Quirion M.R., and Brown M.A. The master switch: The role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 26 (2008) 705-739
185. Schadendorf D., Moller A., Algermissen B., Worm M., Sticherling M., and Czarnetzki B.M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151 (1993) 2667
186. Schwartz L.B., Irani A.A., Roller K., Castells M.C., and Schechter N.M. Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J. Immunol. 138 (1987) 2611-2615
187. Seibold J.R., Giorno R.C., and Claman H.N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum. 33 (1990) 1702-1709
188. Shanahan F., Denburg J.A., Fox J., Bienenstock J., and Befus D. Mast cell heterogeneity: Effect of neuroenteric peptides on histamine release. J. Immunol. 135 (1985) 1331-1337
189. Sharma V.K., Agrawal A.K., Pratarp V.K., Nagar A.M., and Mehrotra M.L. Mast cell reactivity in lymphoma: A preliminary communication. India J. Cancer 29 (1992) 61-65
190. Sher A., Hein A., Moser G., and Caulfield J.P. Complements receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab. Invest. 41 (1979) 490-499
191. Shin J.S., Gao Z., and Abraham S.N. Involvement of cellular caveolae in bacterial entry into mast cells. Science 289 (2000) 785-788
192. Shin K., Watts G.F., Oettgen H.C., Friend D.S., Pemberton A.D., Gurish M.F., and Lee D.M. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J. Immunol. 180 (2008) 4885-4891
193. Sorbo J., Jakobson A., and Norrby K. Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int. J. Exp. Pathol. 75 (1994) 43-50
194. Soucek L., Lawlor E.R., Soto D., Shchors K., Swigart L.B., and Evan G.I. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat. Med. 13 (2007) 1211-1218
195. Stack M.S., and Johnson D.A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269 (1994) 9416-9419
196. v mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer 42 (1988) 48-52
197. Stead R.H., Kosecka-Janiszewska U., Oestreicher A.B., Dixon M.F., and Bienenstock J. Remodeling of B-50 (GAP-43)- and NSE-immunoreactive mucosal nerves in the intestines of rats infected with Nippostrongylis brasiliensis. J. Neurosci. 11 (1991) 3809-3821
198. Stevens R.L., Friend D.S., McNeil H.P., Schiller V., Ghildyal N., and Austen K.F. Stran-specific and tissue-specific of mouse mast cell secretory granule proteases. Proc. Natl. Acad. Sci. USA 91 (1993) 128-132
199. Sun J., Sukhova G.K., Wolters P.J., Yang M., Kitamoto S., Libby P., MacFarlane L.A., Mallen-St Clair J., and Shi G.P. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13 (2007) 719-724
200. Sun J., Sukhova G.K., Yang M., Wolters P.J., MacFarlane L.A., Libby P., Sun C., Zhang Y., Liu J., Ennis T.L., Knispel R., Xiong W., et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117 (2007) 3359-3368
201. Taiplae J., Lohi J., Saarinen J., Kovanen P.T., and Keshi-Oja J. Human mast cell chymase and leukocyte elestase release latent transforming growth factor beta-1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270 (1995) 4689-4696
202. Takanami I., Takeuchi K., and Narume M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88 (2000) 2686-2692
203. Talkington J., and Nickell S.P. Role of Fgγ receptors in triggering host-cell activation and cytokine release by Borrelia burgdorferi. Infect. Immunol. 69 (2001) 413-419
204. Taylor S., and Folkman J. Protamine is an inhibitor of angiogenesis. Nature 297 (1982) 307-312
205. Thabrew H., Cairns J.A., and Walls A.F. Mast cell tryptase is a growth factor for human airway smooth muscle. J. Allergy Clin. Immunol. 97 (1996) 969
206. Thakurdas S.M., Melicoff E., Sansores-Garcia L., Moreira D.C., Petrova Y., Stevens R.L., and Adachi R. The mast cell restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infection. J. Biol. Chem. 282 (2007) 20809-20815
207. Theoharides T., and Conti P. Mast cells: The Jekyll and Hyde of tumor growth. Trends Immunol. 25 (2004) 235-241
208. Theoharides T., Kempuraj D., Tagen M., Conti P., and Kalogeromitros D. Differential release of mast cells mediators and the pathogenesis of inflammation. Immunol. Rev. 217 (2007) 65-78
209. Thompson W.D., Campbell R., and Evans T. Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane. J. Pathol. 145 (1995) 27-37
210. Thorense S., Tangen M., and Hartveit F. Mast cells in the axillary nodes of breast cancer patients. Diagn. Histopathol. 5 (1982) 65-67
211. Thorton S.C., Mueller S.M., and Levine E.M. Human endothelial cells: Use of heparin in cloning and long term cultivation. Science 222 (1983) 623-625
212. Tomita M., Matsuzaki Y., and Onitsuka T. Effect of mast cell on tumor angiogenesis in lung cancer. Ann. Thorac. Surg. 69 (2000) 1686-1690
213. Torunilhac O., Santos D.D., Xu L., Kutok J., Tai Y.T., Le Gouill S., Catley L., Hunter Z., Branagan A.R., Boyce J.A., Munshi N., Anderson K.C., et al. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann. Oncol. 17 (2006) 1275-1282
214. Toth T., Toth-Jakatics R., Jimi S., Takebayashi S., and Kawamoto N. Cutaneous malignant melanoma: Correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum. Pathol. 31 (2000) 955-960
215. Travis W.D., Li C.Y., Yam L.T., Bergstralh E.J., and Swee R.G. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 62 (1988) 965-972
216. Tsai M., Shih L.S., Newlands G.F., Takeishi T., Langley K.E., Zsebo K.M., Miller H.R., Geissler E.N., and Galli S.J. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry and protease phenotype. J. Exp. Med. 174 (1991) 125-131
217. Vanderslice P., Ballinger S.M., Tam E.K., Glodstein S.M., Crail C.S., and Caughey G.M. Human mast cell tryptase: Multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. USA 87 (1990) 3811-3815
218. Vincent A.J., Zhang J., Ostor A., Rogers P.A., Affandi B., Kovacs G., and Salamonsen L.A. Matrix metalloproteinase-1 and-3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum. Reprod. 15 (2000) 123-130
219. Walsh L.J., Trinchieri G., Waldorf H.A., Whiraker D., and Murphy G.F. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88 (1991) 4220-4224
220. Wanachantarak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral Pathol. Med. 32 (2003) 195-199
221. Weller K., Foitzik K., Paus R., Syska W., and Maurer M. Mast cells are required for normal healing of skin wounds in mice. FASEB J. 20 (2006) 2366-2368
222. Welsh T.J., Green R.H., Richardson D., Waller D.A., O'Byrne K.J., and Bradding P. Macrophage and mast cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J. Clin. Oncol. 23 (2005) 8959-8967
223. Wilks J.W., Scott P.S., Urla L.K., and Cocuzza J.M. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int. J. Radiat. Biol. 60 (1991) 73-77
224. Wojtecka-Lukasik E., and Maslinski S. Fibronectin and fibrinogen degradation products stimulate PMN-leukocytes and mast-cell degranulation. J. Physiol. Pharmacol. 43 (1992) 173-181
225. Yamazaki S., Yokozechi H., Satoh T., Katayama I., and Nishioka T. TNF-alpha, RANTES, and MCP-1 are major chemoattractants in murine Langerhans cells to the regional lymoh nodes. Exp. Dermatol. 7 (1998) 35-41
226. Yayou A., Klagsbrun M., Esko J.D., Leder P., and Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its hugh affinity receptor. Cell 64 (1991) 841-848
227. (W-sh) mice does not impair antibody-mediated arthritis. J. Exp. Med. 204 (2007) 2797-2802